Cartesian Therapeutics

IPO

Home - Cartesian Therapeutics

Public · Gaithersburg, United States · Founded 2016 · $7.3M raised

Employees
51–200
Founded
2016
Business Model
B2B
Total Funding
$7.3M
Last Round
$3.0M GrantJun 2024
Rounds
4
Type
Public

About

Cartesian Therapeutics is a NASDAQ-listed clinical-stage biotechnology company pioneering mRNA cell therapies for autoimmune diseases. Its lead program, Descartes-08, is an autologous mRNA-engineered CAR-T therapy targeting BCMA in patients with myasthenia gravis and other autoimmune conditions. Founded in 2016, the company merged with Selecta Biosciences in November 2023 and is based in Gaithersburg, Maryland.

Summary

Cartesian Therapeutics is a Biotech company based in Gaithersburg, United States, founded in 2016. It has raised $7.3M in total across 4 rounds, most recently a $3.0M Grant round in Jun 2024. Investors include HBM Healthcare Investments, Invus and Schooner Capital.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Secondary MarketSecondary MarketJul 2024

Sign up to see all 6 events

Funding: Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Cartesian Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/cartesian-therapeutics"><img src="https://indexed.vc/api/badge/company/cartesian-therapeutics" alt="Cartesian Therapeutics on Indexed.vc" width="260" height="76" /></a>